Skip to main content
. Author manuscript; available in PMC: 2020 Mar 6.
Published in final edited form as: Neuron. 2019 Mar 6;101(5):783–800. doi: 10.1016/j.neuron.2019.02.019

Figure 5. Machine learning in biomarker development.

Figure 5.

Illustration of Neurological Pain Signature and Pain-Analgesia Signature for Analgesic drug development as ‘biomarkers’ currently being developed using machine learning tools and data from human neuroimaging studies.